Literature DB >> 29432186

Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region.

Fleur S van de Bovenkamp1, Ninotska I L Derksen2, Pleuni Ooijevaar-de Heer2, Karin A van Schie2, Simone Kruithof2, Magdalena A Berkowska3, C Ellen van der Schoot3, Hanna IJspeert4, Mirjam van der Burg4, Ann Gils5, Lise Hafkenscheid6, René E M Toes6, Yoann Rombouts6,7,8, Rosina Plomp7, Manfred Wuhrer7, S Marieke van Ham2, Gestur Vidarsson3, Theo Rispens2.   

Abstract

A hallmark of B-cell immunity is the generation of a diverse repertoire of antibodies from a limited set of germline V(D)J genes. This repertoire is usually defined in terms of amino acid composition. However, variable domains may also acquire N-linked glycans, a process conditional on the introduction of consensus amino acid motifs (N-glycosylation sites) during somatic hypermutation. High levels of variable domain glycans have been associated with autoantibodies in rheumatoid arthritis, as well as certain follicular lymphomas. However, the role of these glycans in the humoral immune response remains poorly understood. Interestingly, studies have reported both positive and negative effects on antibody affinity. Our aim was to elucidate the role of variable domain glycans during antigen-specific antibody responses. By analyzing B-cell repertoires by next-generation sequencing, we demonstrate that N-glycosylation sites are introduced at positions in which glycans can affect antigen binding as a result of a specific clustering of progenitor glycosylation sites in the germline sequences of variable domain genes. By analyzing multiple human monoclonal and polyclonal (auto)antibody responses, we subsequently show that this process is subject to selection during antigen-specific antibody responses, skewed toward IgG4, and positively contributes to antigen binding. Together, these results highlight a physiological role for variable domain glycosylation as an additional layer of antibody diversification that modulates antigen binding.

Entities:  

Keywords:  Fab glycosylation; antibody diversification; variable domain glycosylation

Mesh:

Substances:

Year:  2018        PMID: 29432186      PMCID: PMC5828577          DOI: 10.1073/pnas.1711720115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Authors:  Rada Amin; Frédéric Mourcin; Fabrice Uhel; Céline Pangault; Philippe Ruminy; Loic Dupré; Marion Guirriec; Tony Marchand; Thierry Fest; Thierry Lamy; Karin Tarte
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

2.  The amino acid at the X position of an Asn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency.

Authors:  S H Shakin-Eshleman; S L Spitalnik; L Kasturi
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

3.  Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.

Authors:  Yoann Rombouts; Annemiek Willemze; Joyce J B C van Beers; Jing Shi; Priscilla F Kerkman; Linda van Toorn; George M C Janssen; Arnaud Zaldumbide; Rob C Hoeben; Ger J M Pruijn; André M Deelder; Gertjan Wolbink; Theo Rispens; Peter A van Veelen; Tom W J Huizinga; Manfred Wuhrer; Leendert A Trouw; Hans U Scherer; René E M Toes
Journal:  Ann Rheum Dis       Date:  2015-01-13       Impact factor: 19.103

4.  Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.

Authors:  Kalyan Rao Anumula
Journal:  J Immunol Methods       Date:  2012-06-06       Impact factor: 2.303

5.  Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions.

Authors:  D Dunn-Walters; L Boursier; J Spencer
Journal:  Mol Immunol       Date:  2000 Feb-Mar       Impact factor: 4.407

6.  Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies.

Authors:  Karin A van Schie; Pleuni Ooijevaar-De Heer; Simone Kruithof; Chamaida Plasencia; Teresa Jurado; Dora Pascual Salcedo; Johannan F Brandse; Geert Ram d'Haens; Gerrit Jan Wolbink; Theo Rispens
Journal:  Ann Rheum Dis       Date:  2017-04-28       Impact factor: 19.103

7.  Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy.

Authors:  R Urbanek; D M Kemeny; D Richards
Journal:  Clin Allergy       Date:  1986-07

8.  Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma.

Authors:  Dunja Schneider; Marcus Dühren-von Minden; Alabbas Alkhatib; Corinna Setz; Cornelis A M van Bergen; Marco Benkißer-Petersen; Isabel Wilhelm; Sarah Villringer; Sergey Krysov; Graham Packham; Katja Zirlik; Winfried Römer; Christian Buske; Freda K Stevenson; Hendrik Veelken; Hassan Jumaa
Journal:  Blood       Date:  2015-03-17       Impact factor: 22.113

9.  Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity.

Authors:  Zahra Sabouri; Peter Schofield; Keisuke Horikawa; Emily Spierings; David Kipling; Katrina L Randall; David Langley; Brendan Roome; Rodrigo Vazquez-Lombardi; Romain Rouet; Jana Hermes; Tyani D Chan; Robert Brink; Deborah K Dunn-Walters; Daniel Christ; Christopher C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

10.  Systematic characterization and comparative analysis of the rabbit immunoglobulin repertoire.

Authors:  Jason J Lavinder; Kam Hon Hoi; Sai T Reddy; Yariv Wine; George Georgiou
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

View more
  34 in total

Review 1.  Diversity and dynamism of IgA-microbiota interactions.

Authors:  Kelsey E Huus; Charisse Petersen; B Brett Finlay
Journal:  Nat Rev Immunol       Date:  2021-02-10       Impact factor: 53.106

Review 2.  The current status of anti-citrullinated protein antibodies and citrullinated protein-reactive B cells in the pathogenesis of rheumatoid arthritis.

Authors:  Jia He; JiYu Ju; XiaoDong Wang
Journal:  Mol Biol Rep       Date:  2021-12-02       Impact factor: 2.316

Review 3.  Sweet Rules: Linking Glycosylation to Antibody Function.

Authors:  Falk Nimmerjahn; Anja Werner
Journal:  Exp Suppl       Date:  2021

4.  Elevated N-Linked Glycosylation of IgG V Regions in Myasthenia Gravis Disease Subtypes.

Authors:  Caleigh Mandel-Brehm; Miriam L Fichtner; Ruoyi Jiang; Valerie J Winton; Sara E Vazquez; Minh C Pham; Kenneth B Hoehn; Neil L Kelleher; Richard J Nowak; Steven H Kleinstein; Michael R Wilson; Joseph L DeRisi; Kevin C O'Connor
Journal:  J Immunol       Date:  2021-09-20       Impact factor: 5.426

Review 5.  From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis.

Authors:  Hans Ulrich Scherer; Diane van der Woude; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2022-05-23       Impact factor: 32.286

6.  An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.

Authors:  Alice Nevone; Maria Girelli; Silvia Mangiacavalli; Bruno Paiva; Paolo Milani; Pasquale Cascino; Maggie Piscitelli; Valentina Speranzini; Claudio Salvatore Cartia; Pietro Benvenuti; Ibai Goicoechea; Francesca Fazio; Marco Basset; Andrea Foli; Martina Nanci; Giulia Mazzini; Serena Caminito; Melania Antonietta Sesta; Simona Casarini; Paola Rognoni; Francesca Lavatelli; Maria Teresa Petrucci; Pier Paolo Olimpieri; Stefano Ricagno; Luca Arcaini; Giampaolo Merlini; Giovanni Palladini; Mario Nuvolone
Journal:  Leukemia       Date:  2022-05-24       Impact factor: 12.883

Review 7.  Breaking the law: unconventional strategies for antibody diversification.

Authors:  Alexia Kanyavuz; Annaelle Marey-Jarossay; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

8.  Aberrant Immunoglobulin G Glycosylation in Multiple Sclerosis.

Authors:  Peter G E Kennedy; Michael Graner; Tiffany Pointon; Xiaomeng Li; Kayo Tanimoto; Kathryn Dennison; Gina Im; Anthony Fringuello; Wenbo Zhou; Arin Graner; Stefan Sillau; Timothy Vollmer; Xiaoli Yu
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-03       Impact factor: 7.285

9.  H and L Chain Affinity Maturation and/or Fab N-Glycosylation Influence Immunoreactivity toward Neutrophil Extracellular Trap Antigens in Rheumatoid Arthritis Synovial B Cell Clones.

Authors:  Elisa Corsiero; Emanuela Carlotti; Lucas Jagemann; Mauro Perretti; Costantino Pitzalis; Michele Bombardieri
Journal:  J Immunol       Date:  2020-03-27       Impact factor: 5.422

Review 10.  Immunoglobulin germline gene variation and its impact on human disease.

Authors:  Ivana Mikocziova; Victor Greiff; Ludvig M Sollid
Journal:  Genes Immun       Date:  2021-06-26       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.